JP2005036009A5 - - Google Patents

Download PDF

Info

Publication number
JP2005036009A5
JP2005036009A5 JP2004266488A JP2004266488A JP2005036009A5 JP 2005036009 A5 JP2005036009 A5 JP 2005036009A5 JP 2004266488 A JP2004266488 A JP 2004266488A JP 2004266488 A JP2004266488 A JP 2004266488A JP 2005036009 A5 JP2005036009 A5 JP 2005036009A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
aminomethyl
acetic acid
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004266488A
Other languages
English (en)
Japanese (ja)
Other versions
JP3744928B2 (ja
JP2005036009A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2005036009A publication Critical patent/JP2005036009A/ja
Publication of JP2005036009A5 publication Critical patent/JP2005036009A5/ja
Application granted granted Critical
Publication of JP3744928B2 publication Critical patent/JP3744928B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004266488A 1999-10-20 2004-09-14 医薬製剤としての2環式アミノ酸 Expired - Fee Related JP3744928B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16072599P 1999-10-20 1999-10-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001531783A Division JP3632191B2 (ja) 1999-10-20 2000-10-17 医薬製剤としての2環式アミノ酸

Publications (3)

Publication Number Publication Date
JP2005036009A JP2005036009A (ja) 2005-02-10
JP2005036009A5 true JP2005036009A5 (https=) 2005-09-08
JP3744928B2 JP3744928B2 (ja) 2006-02-15

Family

ID=22578159

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001531783A Expired - Fee Related JP3632191B2 (ja) 1999-10-20 2000-10-17 医薬製剤としての2環式アミノ酸
JP2004266488A Expired - Fee Related JP3744928B2 (ja) 1999-10-20 2004-09-14 医薬製剤としての2環式アミノ酸

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001531783A Expired - Fee Related JP3632191B2 (ja) 1999-10-20 2000-10-17 医薬製剤としての2環式アミノ酸

Country Status (50)

Country Link
US (2) US6689906B1 (https=)
EP (2) EP1506955B1 (https=)
JP (2) JP3632191B2 (https=)
KR (2) KR100566462B1 (https=)
CN (1) CN1165518C (https=)
AP (2) AP2004003186A0 (https=)
AR (2) AR026087A1 (https=)
AT (2) ATE358116T1 (https=)
AU (2) AU778871B2 (https=)
BG (2) BG106719A (https=)
BR (1) BR0014972B1 (https=)
CA (1) CA2386297C (https=)
CO (1) CO5280060A1 (https=)
CR (1) CR6620A (https=)
CU (1) CU23112A3 (https=)
CZ (1) CZ295960B6 (https=)
DE (2) DE60019628T2 (https=)
DO (1) DOP2000000083A (https=)
DZ (1) DZ3197A1 (https=)
EA (1) EA005206B1 (https=)
EC (1) ECSP045393A (https=)
EE (1) EE200200211A (https=)
ES (2) ES2237464T3 (https=)
GE (1) GEP20043297B (https=)
GT (2) GT200000183AA (https=)
HK (1) HK1049826B (https=)
HN (1) HN2000000224A (https=)
HR (2) HRP20020428B1 (https=)
HU (1) HUP0203325A3 (https=)
IL (3) IL149143A0 (https=)
IS (2) IS6348A (https=)
MA (1) MA26842A1 (https=)
MX (1) MXPA02003229A (https=)
MY (1) MY127678A (https=)
NO (2) NO20021780D0 (https=)
NZ (1) NZ517961A (https=)
OA (1) OA12070A (https=)
PA (1) PA8505201A1 (https=)
PE (1) PE20010740A1 (https=)
PL (1) PL354607A1 (https=)
PT (1) PT1226110E (https=)
SI (1) SI1226110T1 (https=)
SK (1) SK5232002A3 (https=)
SV (1) SV2001000188A (https=)
TR (2) TR200500221T2 (https=)
TW (2) TW200505824A (https=)
UA (1) UA72931C2 (https=)
WO (1) WO2001028978A1 (https=)
YU (2) YU29302A (https=)
ZA (1) ZA200202543B (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164034B2 (en) 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
IL152770A0 (en) * 2000-06-26 2003-06-24 Warner Lambert Co Gabapentin analogues for sleep disorders
US6620829B2 (en) 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
EP1226820A1 (en) 2001-01-26 2002-07-31 Warner-Lambert Company Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
SK12822003A3 (sk) * 2001-04-19 2004-04-06 Warner - Lambert Company Llc Fúzne bicyklické alebo tricyklické aminokyseliny
GB2375108A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Production of a bicycloheptanone
GB2375109A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Process for preparing bicyclic amino acid
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ATE540678T1 (de) * 2001-06-11 2012-01-15 Xenoport Inc Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
AU2003201716B2 (en) 2002-01-31 2008-04-17 Warner-Lambert Company Llc Alpha 2 delta ligands to treat tinnitus
RU2286151C2 (ru) * 2002-02-22 2006-10-27 Уорнер-Ламберт Компани Ллс Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2
AU2003239752A1 (en) * 2002-06-27 2004-01-19 Warner-Lambert Company Llc Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
US7419981B2 (en) 2002-08-15 2008-09-02 Pfizer Inc. Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
WO2004016260A1 (en) * 2002-08-15 2004-02-26 Pfizer Limited Therapeutic use of fused bicyclic or tricyclic amino acids
GB0219024D0 (en) * 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
WO2004052360A1 (en) 2002-12-11 2004-06-24 Xenoport, Inc. Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
WO2004054560A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Alpha-2-delta ligand to treat lower urinary tract symptoms
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
BR0317253A (pt) 2002-12-13 2005-11-01 Warner Lambert Co Derivados pregabalina para o tratamento da fibromialgia e outras patologias
NZ545494A (en) 2003-09-12 2009-10-30 Pfizer Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
WO2006092692A1 (en) * 2005-03-01 2006-09-08 Pfizer Limited Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
CA2673545A1 (en) 2006-12-22 2008-07-03 Recordati Ireland Limited Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids
BRPI0818193B8 (pt) 2007-09-28 2021-05-25 Daiichi Sankyo Co Ltd composto, composição farmacêutica, e, uso de um composto
JP5557292B2 (ja) 2009-03-26 2014-07-23 第一三共株式会社 二環性γ−アミノ酸誘導体の製造方法
HUE035366T2 (en) 2011-06-08 2018-05-02 Daiichi Sankyo Co Ltd A method for the preparation of a bicyclic compound by Claisen rearrangement
ES2659162T3 (es) 2011-06-08 2018-03-14 Daiichi Sankyo Company, Limited Procedimiento de producción de compuesto bicíclico a través de una sal de iminio
KR101944575B1 (ko) 2011-12-15 2019-04-17 다이이찌 산쿄 가부시키가이샤 부제 촉매를 사용하는 2고리형 화합물의 광학 분할 방법
EP2837689B1 (en) 2012-04-10 2017-02-15 Daiichi Sankyo Company, Limited Optical resolution method for bicyclic compound using enzyme
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
TWI635071B (zh) 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ-胺基酸衍生物及其製造方法
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles
CN113045410A (zh) * 2021-03-29 2021-06-29 华东理工大学 一种双环降二萜类化合物及其合成基因及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641129A (en) 1969-06-17 1972-02-08 Merck & Co Inc Antifibrinolytic compounds
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
ATE323067T1 (de) 1997-10-27 2006-04-15 Warner Lambert Co Zyklische aminosäuren und deren derivate als arzneimittel

Similar Documents

Publication Publication Date Title
JP2005036009A5 (https=)
JP7374951B2 (ja) 安定なカンナビノイド製剤
JP2005506370A5 (https=)
JP2010077141A5 (https=)
JP2006506378A5 (https=)
ATE330589T1 (de) Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
JP2008508303A5 (https=)
WO2005019163A3 (en) Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
JP2018519329A5 (https=)
JP2013513612A5 (https=)
JP2006507220A5 (https=)
JP2020514282A5 (https=)
JP2020520963A5 (https=)
JP2017515840A5 (https=)
JP2010514834A5 (https=)
JP2009513604A5 (https=)
JP2021503483A5 (https=)
JP2016537432A5 (https=)
JP2004513099A (ja) 喘息を治療するためのトルテロジンの使用
JP2019531286A5 (https=)
JP6159885B2 (ja) ジロートンクリーム剤形の局所用抗炎症薬学的組成物
EA200600886A1 (ru) Способ получения солей тиотропия, соли тиотропия, а также содержащие их лекарственные композиции
JP2006501207A5 (https=)
RU2005105688A (ru) Полиморфизм додекагидроциклопента (а) фенантренилового эфира тиофенкарбоновой кислоты
CN106117015B (zh) 一种共轭二炔二醇类化合物及其用途